Pacira Biosciences Inc (PCRX) returns
Pacira Biosciences returns over 10 years
$1,000 invested in Pacira Biosciences ten years ago was worth $1,098 at the close on October 30, 2026, with dividends reinvested: an average return of 0.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +45.3% | — | $1,453 | -0.9% |
| 3 months | +34.9% | — | $1,349 | +2.1% |
| Year to date | +40.6% | — | $1,406 | +11.7% |
| 1 year | +71.1% | — | $1,711 | +12.4% |
| 3 years | +31.0% | +9.4% | $1,310 | +88.5% |
| 5 years | -30.4% | -7.0% | $696.06 | +76.0% |
| 10 years | +9.8% | +0.9% | $1,098 | +316.6% |
Pacira Biosciences return by calendar year
| Year | PCRX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +40.6% | +11.7% | +28.9% |
| 2025 | +37.4% | +17.7% | +19.7% |
| 2024 | -44.2% | +24.9% | -69.0% |
| 2023 | -12.6% | +26.2% | -38.8% |
| 2022 | -35.8% | -18.2% | -17.7% |
| 2021 | +0.6% | +28.7% | -28.2% |
| 2020 | +32.1% | +18.4% | +13.7% |
| 2019 | +5.3% | +31.2% | -25.9% |
| 2018 | -5.8% | -4.6% | -1.2% |
| 2017 | +41.3% | +21.7% | +19.6% |
| 2016 | -57.9% | +12.0% | -69.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: PCRX financials · PCRX valuation
No forecast, no recommendation. This page describes Pacira Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.